The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Cyano-3-(3,4-dihydroxy-phenyl)-acrylic acid phenethyl ester ID: ALA37154
PubChem CID: 14840972
Max Phase: Preclinical
Molecular Formula: C18H15NO4
Molecular Weight: 309.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#C/C(=C\c1ccc(O)c(O)c1)C(=O)OCCc1ccccc1
Standard InChI: InChI=1S/C18H15NO4/c19-12-15(10-14-6-7-16(20)17(21)11-14)18(22)23-9-8-13-4-2-1-3-5-13/h1-7,10-11,20-21H,8-9H2/b15-10+
Standard InChI Key: VSHGPCHQEFUWCE-XNTDXEJSSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
4.5417 -4.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8292 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2542 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -2.7042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -3.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1125 -4.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 -3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1125 -3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9667 -4.3542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 -4.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2542 -5.5917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -2.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9667 -3.1167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -6.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8292 -7.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -6.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -6.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8375 -8.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1292 -8.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4042 -7.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4042 -8.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 4 3 0
6 9 2 0
7 2 1 0
8 11 2 0
9 7 1 0
10 3 2 0
11 13 1 0
12 3 1 0
13 7 2 0
14 6 1 0
15 8 1 0
16 12 1 0
17 18 1 0
18 16 1 0
19 17 2 0
20 17 1 0
21 20 2 0
22 19 1 0
23 21 1 0
8 6 1 0
23 22 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 309.32Molecular Weight (Monoisotopic): 309.1001AlogP: 2.79#Rotatable Bonds: 5Polar Surface Area: 90.55Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.41CX Basic pKa: ┄CX LogP: 3.73CX LogD: 3.69Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.38Np Likeness Score: -0.04
References 1. Cho H, Ueda M, Tamaoka M, Hamaguchi M, Aisaka K, Kiso Y, Inoue T, Ogino R, Tatsuoka T, Ishihara T.. (1991) Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase., 34 (4): [PMID:2016727 ] [10.1021/jm00108a039 ] 2. Rodrigues N, Bennis K, Vivier D, Pereira V, C Chatelain F, Chapuy E, Deokar H, Busserolles J, Lesage F, Eschalier A, Ducki S.. (2014) Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel., 75 [PMID:24561669 ] [10.1016/j.ejmech.2014.01.049 ]